Clinical Trials Browser

Lymphoma, Non-Hodgkin × zanubrutinib × Clear all

NCT06563596 2026-02-19

Epco, Zanu, Ritux for R/R FL or MZL

Phase 2 Recruiting

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Marginal Zone

NCT04002297 2025-09-26

MANGROVE

Phase 3 Active not recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT04662255 2025-05-28

BRUIN-MCL-321

Phase 3 Active not recruiting

Hematologic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT06646211 2024-10-17

High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

Phase 2 Not yet recruiting

Lymphoma, Non-Hodgkin

NCT06427213 2024-05-23

This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma

Phase 2 Not yet recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT05200312 2022-03-11

ZR2-CHOP

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse